AMRX Amneal Pharmaceuticals
$20.30 -0.27%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-0.27%
YTD
+95.90%
P/E
41.2
P/B
140.74
ROE
174.6%
Div yield
—
Beta
0.63
Market cap
$6.5B
RSI (14)
64
Next earnings
Oct 29, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$20.53
Close
$20.30
VWAP (n/a)
—
Day high
$20.60
Day low
$20.00
Volume
3.6M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
3 Low-Volatility Stocks with Open Questions
Yahoo Finance · Oct 5
Amneal Pharmaceuticals (AMRX) Stock Gets Fair Value Bump After Analyst Backing For New Launches
Yahoo Finance · Oct 3
Why Is Amneal (AMRX) Stock Rocketing Higher Today
Yahoo Finance · Sep 22
Amneal Announces FDA Approval and Launch of Lanreotide Injection
Yahoo Finance · Sep 18
3 Reasons to Avoid AMRX and 1 Stock to Buy Instead
Yahoo Finance · Sep 18
Amneal (AMRX) Surges 8.6%: Is This an Indication of Further Gains?
Yahoo Finance · Sep 17
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 10, 2026 View → 10-Q Aug 6, 2026 View → 8-K Aug 3, 2026 View → 8-K Jul 31, 2026 View → 8-K Jul 30, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell AMRX. Try it in the Lab to size a position and see the risk.